SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction

Clinical trial NCT02348489 · COMPLETED

Trial details

NCT number: NCT02348489
Sponsor: Astex Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2015-03-19
Primary completion: 2018-05-31
Enrollment: 815

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.